Back to top
more

Verano Holdings Corp. (VRNOF)

(Delayed Data from OTC)

$3.64 USD

3.64
1,098,496

+0.12 (3.27%)

Updated Jul 8, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 249)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for VRNOF

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

4 items in cart

View Cart/Checkout

Verano Holdings Corp. [VRNOF]

Reports for Purchase

Showing records 121 - 140 ( 145 total )

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 121

08/17/2022

Company Report

Pages: 8

2Q22 Mixed, Heavy Investment & NJ to Drive 2H22 Growth, Lower PT to $21

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 122

08/15/2022

Industry Report

Pages: 8

Weekly ReHash: 2Q22 Cannabis Earnings - Week II Preview

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 123

08/12/2022

Daily Note

Pages: 5

Cannabis Industry Update: 2Q22 Week II Earnings Preview

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 124

08/05/2022

Industry Report

Pages: 8

Weekly ReHash: 2Q22 Cannabis Earnings

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 125

08/03/2022

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 126

07/29/2022

Industry Report

Pages: 7

Weekly ReHash: MSO Uplisting Process, How SAFE Potentially Creates a Path

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 127

07/19/2022

Daily Note

Pages: 14

U.S. Cannabis 2Q22 Preview: Macro Impacting NT, Legislative Progess Warming

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 128

07/11/2022

Industry Report

Pages: 8

Weekly ReHash: Operating Income Gaining Investor Interest As Industry Matures

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 129

06/13/2022

Industry Report

Pages: 8

Weekly ReHash: Alternative Cannabinoids

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 130

06/07/2022

Industry Report

Pages: 30

Signs of Recovery But Increasing Taxes Payable Pose a Challenge for H2/22

Provider: VENTUM CAPITAL MARKETS

Analyst: ZANDBERG J

Price: 35.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 131

06/06/2022

Industry Report

Pages: 8

Weekly ReHash: Consumer Access Key - Opening More Retail Licenses

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 132

05/27/2022

Industry Report

Pages: 8

Weekly ReHash: Deferred Taxes, Another Low "Cost" Cash Opportunity

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 133

05/26/2022

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 134

05/26/2022

Company Report

Pages: 8

1Q22 In-Line As Expected, Set Up to Drive Leading Margins, Reit Buy

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 135

05/24/2022

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 136

05/24/2022

Industry Report

Pages: 2

NJ Adult-Use Cannabis Update: New Recreational Stores Added to Begin Sales

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 137

05/23/2022

Company Report

Pages: 5

1Q22 Preview, NJ Investment/ Positioning to Drive Growth

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 138

04/28/2022

Company Report

Pages: 13

4Q21 Messy with GAAP Transition, Still Best-in-Class, Lower PT to $26 - Buy

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 139

04/28/2022

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Verano Holdings Corp.

Industry: Medical - Products

Record: 140

04/27/2022

Company Report

Pages: 8

Q421 Results Show Larger than Expected Margin Blip Which will Persist into Q122, Upwards from Then, $240M Est. Operating Cashflow in 2022

Provider: Echelon Welath Partners

Analyst: SEMPLE A

Price: 12.50

Research Provided by a Third Party